Changes in Mitochondrial Uncoupling Protein 2 (UCP2) Messenger RNA(mRNA) in Type 2 Diabetes (T2DM) Patients

Tel Aviv Sourasky Medical Center

Status: Unknown

Conditions: Diabetes

Treatments: Procedure: Blood withdrawal

Study type: Observational

Funder types: Other

Identifiers

NCT01781754

TASMC-11-NV-561-CTIL

Details and patient eligibility

About

Many patients with Diabetes find difficulties in achieving glycemic control. Hemoglobin A1c(HgBA1c) is used as a marker for glycemic control. UCP2 is affected by high glucose levels, high free fatty acids and high oxidative stress.

The investigators intend to learn about the changes in UCP2 along the process of reaching glycemic control.

Enrollment: 50 estimated patients

Sex: All

Ages: 20 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Un balanced diabetic patients.

Exclusion criteria

• No current infection.

Trial design

50 participants in 1 patient group

Diabetic patients

Description:

Un balanced diabetic patients

Treatment:

Procedure: Blood withdrawal